PUBLISHER: The Business Research Company | PRODUCT CODE: 1942798
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942798
Electrophysiology devices and equipment serve in diagnosing and treating heart rhythm disorders by analyzing electrical activity.
Primary product categories within electrophysiology devices and equipment comprise electrophysiology ablation catheters, diagnostic catheters, and lab systems. Electrophysiology ablation catheters assess heart electrical activity, identifying irregular heart rhythms. Various monitoring tools encompass electrocardiographs (ECG), electroencephalographs (EEG), electrocorticographs (ECoG), electromyographs (EMG), electroretinographs (ERG), electrooculographs (EOG), Holter monitoring devices, X-ray systems, imaging, 3D mapping systems, and diagnostic electrophysiology catheters employed in the analysis of atrioventricular nodal reentry tachycardia (AVERT), Wolff-Parkinson-White syndrome (WPW), atrial flutter, and atrial fibrillation. These devices and equipment cater to hospitals, diagnostic centers, and clinics.
Tariffs are impacting the electrophysiology devices and equipment market by increasing costs of imported catheters, mapping systems, imaging components, electronic sensors, and navigation technologies used in diagnostic and ablation procedures. Hospitals and cardiac centers in North America and Europe are most affected due to dependence on imported high-precision devices, while Asia-Pacific faces cost pressures on manufacturing and exports. These tariffs are increasing procedural equipment costs and slowing lab expansion. However, they are also encouraging local manufacturing, regional supplier partnerships, and innovation in cost-efficient electrophysiology solutions.
The electrophysiology devices and equipment market research report is one of a series of new reports from The Business Research Company that provides electrophysiology devices and equipment market statistics, including electrophysiology devices and equipment industry global market size, regional shares, competitors with a electrophysiology devices and equipment market share, detailed electrophysiology devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the electrophysiology devices and equipment industry. This electrophysiology devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The electrophysiology devices and equipment market size has grown strongly in recent years. It will grow from $7.9 billion in 2025 to $8.57 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising incidence of cardiac arrhythmias, increasing adoption of interventional cardiology procedures, expansion of electrophysiology labs, growing availability of advanced cardiac devices, rising awareness of heart rhythm disorders.
The electrophysiology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $12.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for personalized cardiac treatment, rising adoption of ai-assisted electrophysiology systems, expansion of outpatient cardiac procedures, growing investments in cardiac care infrastructure, increasing focus on treatment outcome optimization. Major trends in the forecast period include increasing adoption of advanced cardiac mapping systems, rising demand for minimally invasive ablation technologies, growing integration of 3D imaging and navigation systems, expansion of catheter-based electrophysiology procedures, enhanced focus on precision cardiac diagnostics.
The growing prevalence of cardiovascular diseases (CVD) is expected to drive the expansion of the electrophysiology devices and equipment market in the future. CVD encompasses a variety of heart and blood vessel conditions, including arrhythmias, coronary artery disease, heart failure, and atrial fibrillation, all of which often require accurate diagnosis and treatment through electrophysiological procedures. The rise in CVD cases is primarily linked to unhealthy lifestyle habits such as poor diet, lack of physical activity, tobacco use, and excessive alcohol consumption. Electrophysiology devices and equipment are crucial for diagnosing, monitoring, and treating these conditions, contributing to the increased demand for specialized CVD care. For example, in September 2024, the Minnesota Department of Health, a state health agency in the US, reported that about 30% of adults in Minnesota had high blood pressure in 2023, totaling nearly 1.4 million individuals. Additionally, in 2022, hypertensive diseases were a primary or contributing factor in the deaths of 14,225 residents, accounting for nearly 28% of all deaths in the state. As a result, the rising prevalence of CVD is fueling growth in the electrophysiology devices and equipment market.
Leading companies in the electrophysiology devices and equipment market are concentrating on technological advancements, particularly in cardiac mapping and ablation technologies, to enhance treatment accuracy and procedural efficiency for atrial fibrillation (AF). Navigation-enabled cardiac mapping refers to systems that integrate real-time visualization, magnetic navigation, and therapy delivery into a single catheter platform, boosting procedural confidence and minimizing the need for multiple device exchanges during interventions. For example, in October 2024, Boston Scientific, a US-based medical device company, introduced the FARAWAVE NAV Ablation Catheter and FARAVIEW Software, which work in conjunction with the FARAPULSE Pulsed Field Ablation system. These innovations offer magnetic tracking and visualization of catheter placement and pulsed field therapy delivery during AF ablation, optimizing workflows and enhancing physicians' treatment capabilities.
In November 2023, Johnson & Johnson MedTech, a US-based leader in medical technologies, finalized its acquisition of Laminar, Inc. for around $400 million. This acquisition allows Johnson & Johnson MedTech to strengthen its electrophysiology devices portfolio by incorporating Laminar's cutting-edge left atrial appendage elimination (LAAX) technology, which utilizes rotational motion to lower stroke risk in patients with non-valvular atrial fibrillation. Laminar, Inc., a US-based medical device company, specializes in developing solutions for stroke prevention in Atrial Fibrillation (AFib) patients.
Major companies operating in the electrophysiology devices and equipment market are Boston Scientific Corporation, Abbott Laboratories, GE Healthcare, Philips Healthcare, Biotronik SE & Co. KG, Medtronic plc, Biosense Webster Inc., Microport Scientific Corporation, Japan Lifeline Co., C.R. Bard, Mennen Medical Ltd., HeNan HuaNan Medical Science and Technology Co. LTD., Nihon Kohden Corporation, Cardiva Medical Inc., Biotelemetry, Bioheart Inc., Asahi Intecc Co. Ltd., Siemens Healthineers, Lepu Medical Technology (Beijing) Co. Ltd, Acutus Medical Inc., Imricor Medical Systems, Johnson & Johnson
North America was the largest region in the global electrophysiology devices and equipment market in 2025. Western Europe was the second-largest region in the global electrophysiology devices and equipment market. The regions covered in the electrophysiology devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the electrophysiology devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The electrophysiology devices and equipment market consist of sales of ablation catheters, diagnostic catheters, mapping system, accessories, and other electrophysiology devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Electrophysiology Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses electrophysiology devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for electrophysiology devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electrophysiology devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.